Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,801 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10.
Nakamoto S, Iwamoto T, Taira N, Kajiwara Y, Kawada K, Takabatake D, Miyoshi Y, Kubo S, Suzuki Y, Yamamoto M, Ogasawara Y, Hatono M, Yoshitomi S, Hara K, Sasahara A, Ohsumi S, Ikeda M, Doihara H, Mizota Y, Yamamoto S, Shien T, Toyooka S. Nakamoto S, et al. Among authors: suzuki y. Breast Cancer. 2024 Sep;31(5):969-978. doi: 10.1007/s12282-024-01610-5. Epub 2024 Jul 9. Breast Cancer. 2024. PMID: 38980571 Clinical Trial.
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Kawada K, Taira N, Mizoo T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kochi M, Abe Y, Nishiyama K, Iwamoto T, Ikeda H, Shien T, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Toyooka S. Kawada K, et al. Among authors: suzuki y. Breast Cancer. 2021 Mar;28(2):478-487. doi: 10.1007/s12282-020-01185-x. Epub 2020 Nov 13. Breast Cancer. 2021. PMID: 33185851 Free article.
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer.
Suzuki Y, Iwamoto T, Uno M, Hatono M, Kajiwara Y, Takahashi Y, Kochi M, Shien T, Kikawa Y, Uemura Y, Hagiwara Y, Yamamoto S, Taira N, Doihara H, Toyooka S. Suzuki Y, et al. Breast Cancer. 2023 Sep;30(5):856-868. doi: 10.1007/s12282-023-01480-3. Epub 2023 Jul 8. Breast Cancer. 2023. PMID: 37422608
Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for Breast Cancer: A Randomized Controlled Trial From the Setouchi Breast Project-10.
Iwamoto T, Kajiwara Y, Kawada K, Takabatake D, Miyoshi Y, Kubo S, Suzuki Y, Yamamoto M, Ogasawara Y, Hatono M, Yoshitomi S, Hara K, Sasahara A, Ohsumi S, Ikeda M, Doihara H, Mizota Y, Yamamoto S, Taira N. Iwamoto T, et al. Among authors: suzuki y. Clin Breast Cancer. 2024 Jan;24(1):27-35.e8. doi: 10.1016/j.clbc.2023.09.008. Epub 2023 Sep 17. Clin Breast Cancer. 2024. PMID: 37852895 Clinical Trial.
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Hatono M, Ikeda H, Suzuki Y, Kajiwara Y, Kawada K, Tsukioki T, Kochi M, Suzawa K, Iwamoto T, Yamamoto H, Shien T, Yamane M, Taira N, Doihara H, Toyooka S. Hatono M, et al. Among authors: suzuki y. Breast Cancer Res Treat. 2021 Jan;185(2):307-316. doi: 10.1007/s10549-020-05957-z. Epub 2020 Oct 9. Breast Cancer Res Treat. 2021. PMID: 33034801 Free article.
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Takahashi Y, Iwamoto T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, Matsuoka J, Doihara H, Toyooka S. Takahashi Y, et al. Among authors: suzuki y. Clin Breast Cancer. 2020 Apr;20(2):117-124.e4. doi: 10.1016/j.clbc.2019.07.001. Epub 2019 Sep 9. Clin Breast Cancer. 2020. PMID: 31570267 Free article.
Influences of preoperative metformin on immunological factors in early breast cancer.
Tsukioki T, Shien T, Tanaka T, Suzuki Y, Kajihara Y, Hatono M, Kawada K, Kochi M, Iwamoto T, Ikeda H, Taira N, Doihara H, Toyooka S. Tsukioki T, et al. Among authors: suzuki y. Cancer Chemother Pharmacol. 2020 Jul;86(1):55-63. doi: 10.1007/s00280-020-04092-2. Epub 2020 Jun 12. Cancer Chemother Pharmacol. 2020. PMID: 32533334 Free PMC article.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Takabatake D, Kajiwara Y, Ohtani S, Suzuki Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Shien T, Taira N, Doihara H. Takabatake D, et al. Among authors: suzuki y. Acta Med Okayama. 2021 Jun;75(3):357-362. doi: 10.18926/AMO/62231. Acta Med Okayama. 2021. PMID: 34176940 Free article. Clinical Trial.
Evaluation of Prognosis of Juvenile Differentiated Thyroid Carcinoma.
Tsukioki T, Shien T, Ohtani Y, Fujihara M, Suzuki Y, Kajihara Y, Hatono M, Kawada K, Kochi M, Iwamoto T, Ikeda H, Taira N, Doihara H. Tsukioki T, et al. Among authors: suzuki y. Acta Med Okayama. 2020 Oct;74(5):401-406. doi: 10.18926/AMO/60799. Acta Med Okayama. 2020. PMID: 33106695 Free article.
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.
Fujihara M, Shien T, Shien K, Suzawa K, Takeda T, Zhu Y, Mamori T, Otani Y, Yoshioka R, Uno M, Suzuki Y, Abe Y, Hatono M, Tsukioki T, Takahashi Y, Kochi M, Iwamoto T, Taira N, Doihara H, Toyooka S. Fujihara M, et al. Among authors: suzuki y. Int J Mol Sci. 2021 Nov 26;22(23):12809. doi: 10.3390/ijms222312809. Int J Mol Sci. 2021. PMID: 34884609 Free PMC article.
16,801 results
You have reached the last available page of results. Please see the User Guide for more information.